Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation

Ann Hematol. 2007 Dec;86(12):927-30. doi: 10.1007/s00277-007-0330-6. Epub 2007 Jun 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biopsy
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Dexamethasone / administration & dosage
  • Doxorubicin / administration & dosage
  • Glomerular Mesangium / chemistry
  • Glomerular Mesangium / pathology
  • Glomerulonephritis / etiology*
  • Humans
  • Immunoglobulin kappa-Chains / analysis
  • Magnetic Resonance Imaging
  • Male
  • Melphalan / administration & dosage
  • Middle Aged
  • Multiple Myeloma / complications*
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / surgery
  • Myeloma Proteins / analysis
  • Peripheral Blood Stem Cell Transplantation*
  • Proteinuria / etiology*
  • Remission Induction
  • Transplantation, Autologous
  • Vincristine / administration & dosage

Substances

  • Immunoglobulin kappa-Chains
  • Myeloma Proteins
  • Vincristine
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide
  • Melphalan

Supplementary concepts

  • VAD protocol